Phenylketonuria: Genotype-phenotype correlations based on expression analysis of structural and functional mutations inPAH
Open Access
- 19 March 2003
- journal article
- research article
- Published by Hindawi Limited in Human Mutation
- Vol. 21 (4) , 370-378
- https://doi.org/10.1002/humu.10198
Abstract
When analyzed in the context of the phenylalanine hydroxylase (PAH) three‐dimensional structure, only a minority of the PKU mutations described world‐wide affect catalytic residues. Consistent with these observations, recent data point to defective folding and subsequent aggregation/degradation as a predominant disease mechanism for several mutations. In this work, we use a combined approach of expression in eukaryotic cells at different temperatures and a prokaryotic system with co‐expression of chaperonins to elucidate and confirm structural consequences for 18 PKU mutations. Three mutations are located in the amino terminal regulatory domain and 15 in the catalytic domain. Four mutations were found to abolish the specific activity in all conditions. Two are catalytic mutations (Y277D and E280K) and two are severe structural defects (IVS10–11G>A and L311P). All the remaining mutations (D59Y, I65T, E76G, P122Q, R158Q, G218V, R243Q, P244L, R252W, R261Q, A309V, R408Q, R408W, and Y414C) are folding defects causing reduced stability and accelerated degradation, although some of them probably affect residues involved in regulation. In these cases, we have demonstrated that the amount of mutant PAH protein and residual activity could be modulated by in vitro experimental conditions, and therefore the observed in vivo metabolic variation may be explained by interindividual variation in the quality control systems. The results derived provide an experimental framework to define the mutation severity relating genotype to phenotype. They also explain the observed inconsistencies for some mutations in patients with similar genotype and different phenotypes. Hum Mutat 21:370–378, 2003.Keywords
Funding Information
- ‘Fundación Ramón Areces’ grant to the Centro de Biología Molecular “Severo Ochoa”
- Comisión Interministerial de Ciencia y Tecnología (PM98-003, SAF2001-0544)
This publication has 27 references indexed in Scilit:
- PAHdb 2003: What a locus-specific knowledgebase can doHuman Mutation, 2003
- HowPAH gene mutations cause hyper-phenylalaninemia and why mechanism matters: Insights from in vitro expressionHuman Mutation, 2003
- Missense Mutations in the N-Terminal Domain of Human Phenylalanine Hydroxylase Interfere with Binding of Regulatory PhenylalanineAmerican Journal of Human Genetics, 2001
- In Vitro Expression of 34 Naturally Occurring Mutant Variants of Phenylalanine Hydroxylase: Correlation with Metabolic Phenotypes and Susceptibility toward Protein AggregationMolecular Genetics and Metabolism, 2001
- The Structural Basis of PhenylketonuriaMolecular Genetics and Metabolism, 1999
- Genetic and phenotypic aspects of phenylalanine hydroxylase deficiency in Spain: molecular survey by regionsEuropean Journal of Human Genetics, 1999
- A European Multicenter Study of Phenylalanine Hydroxylase Deficiency: Classification of 105 Mutations and a General System for Genotype-Based Prediction of Metabolic PhenotypeAmerican Journal of Human Genetics, 1998
- The Molecular Chaperone Hsc70 Assists the in VitroFolding of the N-terminal Nucleotide-binding Domain of the Cystic Fibrosis Transmembrane Conductance RegulatorPublished by Elsevier ,1997
- Comparison between medium-chain acyl-CoA dehydrogenase mutant proteins overexpressed in bacterial and mammalian cellsHuman Mutation, 1995
- Aberrant splicing of phenylalanine hydroxylase mRNA: The major cause for phenylketonuria in parts of southern EuropeGenomics, 1991